Calcium Dobesilate

羟苯磺酸钙

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NameCalcium Dobesilate
Drug Alias Name二羟基苯磺酸钙calcii dobesilasdobesilato de calcio2，5-二羟苯磺酸钙Doxium +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2Venous InsufficiencyArteriosclerosis Obliterans +[5] 
Global Approved IndicationsVenous InsufficiencyDiabetic RetinopathyHemorrhoids
Approved Indications in ChinaDiabetic RetinopathyHemorrhoids
Original Approved Country/TerritorySwitzerland
Original Approved Date1975/12/15
Country/TerritorySwitzerlandUnited KingdomEU +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesOm Pharma SaXi'An Lijun Pharmaceutical Co LtdGuizhou Bailing Group Pharmaceutical Co Ltd
Inactive CompaniesXinxiang Heping Hospital
Active IndicationsDiabetes Mellitus, Type 2Venous InsufficiencyDiabetic Retinopathy +[4] 
Inactive IndicationsArteriosclerosis Obliterans

Other Information

ATC CodeC05BX01
Related LinksWikipediaKEGG